- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

FDA approves Genentech and AbbVie’s Venclexta combination to treat AML

Bone marrow aspirate showing acute myeloid leukemia. Credit: VashiDonsk.